Conclusion
Vitamin D supplementation has been reported to slightly lower the risk of acute respiratory infections such as colds. Across the whole population, though, the effect is small, and it is not a simple matter of broadly boosting immunity.
The benefit is most visible in people who are markedly deficient in vitamin D, while those who already have adequate levels tend to see little additional effect.
How much does it help?
A 2021 meta-analysis found a slight reduction in infection risk with supplementation (odds ratio 0.92). A 2024 update that added large new trials showed an even smaller effect (odds ratio 0.94, with the upper confidence limit near 1.00), so the overall benefit is very modest.
By contrast, daily or weekly supplementation in people with markedly low blood levels (severe deficiency) has been linked to clearer protection. Giving a large amount in a single bolus tends to be less effective.
What the research shows
The evidence base includes a meta-analysis of 46 randomized trials covering about 64,000 people. In recent large trials, the added benefit for the general population was limited. Effects against COVID-19 were also not confirmed in large trials published in 2022. Results shift with baseline deficiency and with how often the dose is given.
Cautions
- Taking too much carries risks such as high blood calcium; more is not better
- Vitamin D also comes from sunlight and food, so it is practical to review overall habits before relying on supplements alone
- People with kidney or parathyroid conditions should consult a physician before starting
- A blood test shows whether you are actually deficient; testing is reasonable when in doubt
A simple analogy
Supplementing vitamin D is a bit like filling a gap that is missing. The larger the gap (the more deficient you are), the more visible the effect of filling it; for someone already topped up, adding more changes little.